Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma

Frontiers of Medicine in China

Volumn 4, Issue 4, 2010, Pages 430-435

  Wang, Xi Yan ^a   Li, Hai Jun ^a   Wen, Hao ^a   Yan, Dong ^a   Peng, Shu Yong ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

neoadjuvant therapy; pancreatic neoplasms; survival

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOMA; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650715698     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-010-0700-7     Document Type: Article

References (18)

1. Kern S, Hruban R, Hollingsworth M A, Brand R, Adrian T E, Jaffee E, Tempero M A. A white paper: the product of a pancreas cancer think tank. Cancer Res, 2001, 61(12): 4923-4932.
2. Au E. Clinical update of gemcitabine in pancreas cancer. Gan To Kagaku Ryoho, 2000, 27(Suppl 2): 469-473.
3. Wagner M, Redaelli C, Lietz M, Seiler C A, Friess H, Büchler M W. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg, 2004, 91(5): 586-594.
4. Yekebas E F, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist Y K, Schurr P G, Liebl L, Thieltges S, Gawad K A, Schneider C, Izbicki J R. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg, 2008, 247(2): 300-309.
5. Sun C Y, Chen Z L. Attach Importance of Combined Modality Therapy for Pancreatic Carcinomas. Zhonghua Xiao HuaWai Ke Za Zhi, 2009, 8(4): 244-246 (in chinese).
6. Cheng D H, Liu Y F. TNM staging of pancreatic carcinomas. Zhongguo Shi Yong Wai Ke Za Zhi, 2004, 24(5): 320 (in chinese).
7. Wu W D, Peng C H, Zhao D J, Zhou G W, Xiao W D, Li H W. The importance of superior mesenteric-portal vein resection for radical duodenopancreatectomy of pancreatic adenocarcinoma. Zhonghua Pu Tong Wai Ke Za Zhi, 2006, 21(9): 620-622 (in chinese).
8. Qin R Y, Zou S Q, Qiu F Z. The technique of radical pancreaticoduodenectomy for malignant tumor in pancreatic head with pressed superior mesenteric blood vessels or portal vein. Zhonghua Wai Ke Za Zhi, 2008, 46(5): 366-369 (in chinese).
9. Cress R D, Yin D, Clarke L, Bold R, Holly E A. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control, 2006, 17(4): 403-409.
10. Saif M W. Is there a standard of care for the management of advanced pancreatic cancer? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008. JOP, 2008, 9(2): 91-98.
11. Wray C J, Ahmad S A, Matthews J B, Lowy A M. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology, 2005, 128(6): 1626-1641.
12. Saif M W. Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006. JOP, 2006, 7(4): 337-348.
13. Neoptolemos J P, Stocken D D, Friess H, Bassi C, Dunn J A, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr D J, Büchler M W. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 2004, 350(12): 1200-1210.
14. Hosch S B, Knoefel W T, Metz S, Stoecklein N, Niendorf A, Broelsch C E, Izbicki J R. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas, 1997, 15(2): 154-159.
15. Tawada K, Yamaguchi T, Kobayashi A, Ishihara T, Sudo K, Nakamura K, Hara T, Denda T, Matsuyama M, Yokosuka O. Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer. Pancreas, 2009, 38(1): 30-35.
16. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein W O, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA, 2007, 297(3): 267-277.
17. Jin C, Yao L, Long J, Fu D L, Yu X J, Xu J, Yang F, Ni Q X. Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma. Chin Med J (Engl), 2009, 122(3): 284-290.
18. Sultana A, Smith C T, Cunningham D, Starling N, Neoptolemos J P, Ghaneh P. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol, 2007, 25(18): 2607-2615.